| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 333.671 | 924.314 | 932.553 | - | 369.989 |
| Total Income - EUR | - | - | - | - | - | 340.082 | 925.203 | 942.103 | - | 406.298 |
| Total Expenses - EUR | - | - | - | - | - | 150.663 | 692.511 | 775.010 | - | 485.586 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 189.419 | 232.692 | 167.093 | - | -79.288 |
| Net Profit/Loss - EUR | - | - | - | - | - | 186.253 | 224.558 | 158.776 | - | -79.288 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | - | 1 |
Check the financial reports for the company - Medfarm Exim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 102.152 | - | 18.921 |
| Current Assets | - | - | - | - | - | 193.754 | 417.273 | 788.381 | - | 715.769 |
| Inventories | - | - | - | - | - | 757 | 80.608 | 90.195 | - | 127.006 |
| Receivables | - | - | - | - | - | 188.836 | 310.646 | 636.113 | - | 584.716 |
| Cash | - | - | - | - | - | 4.161 | 26.019 | 62.073 | - | 4.046 |
| Shareholders Funds | - | - | - | - | - | 186.294 | 406.721 | 566.758 | - | 462.752 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | - | 40 |
| Debts | - | - | - | - | - | 7.460 | 10.552 | 323.776 | - | 271.938 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Medfarm Exim S.r.l.